To acquire these data, an international collaboration led by Lazarus and Ayman El-Mohandes, Dean of CUNY SPH, carried out a series of surveys beginning in 2020 across 23 highly inhabited nations that were hit hard by the pandemic (Brazil, Canada, China, Ecuador, France, Germany, Ghana, India, Italy, Kenya, Mexico, Nigeria, Peru, Poland, Russia, Singapore, South Africa, South Korea, Spain, Sweden, Turkey, the United Kingdom and the United States). The data reported here correspond to the 3rd study carried out in between June and July 2022.
Of the 23,000 respondents (1000 per country surveyed), 79.1% were ready to accept vaccination. The determination of parents to immunize their children likewise increased slightly, from 67.6% in 2021 to 69.5% in 2022. 8 countries observed increased hesitancy (from 1.0% in the UK to 21.1% in South Africa).
The survey also provides new details on COVID-19 treatments received. Worldwide, ivermectin was taken with the exact same frequency as other authorized medications, even though the WHO and other agencies do not suggest its use to deal with or avoid COVID-19.
Likewise, nearly 40% of respondents reported paying less attention to new COVID-19 info than in the past and having less assistance for vaccine mandates.
The diverse nature of vaccine hesitancy.
In some nations, vaccine hesitancy was related to variables like female sex (e.g., China, Poland and Russia), no university degree (e.g., France, Poland, South Africa, Sweden and the United States), or lower income (e.g., Canada, Germany, Turkey and the UK). Even more, the profile of individuals paying less attention to the pandemic varied among countries.
” Our outcomes show that public health methods to enhance booster protection will need to be more advanced and adaptable for each setting and target population,” says Lazarus. “Strategies to enhance vaccine approval should both consist of messages that emphasize compassion over fear and use relied on messengers, particularly health care employees,” he adds.
In general, the information provided in the surveys can prove useful for health system decision-makers, researchers, advocates and professionals to deal with COVID-19 vaccine hesitancy better. The new research study follows on the heels of an international agreement statement on ending COVID-19 as a public health hazard, which Lazarus, El-Mohandes and 364 co-authors from 112 nations released in Nature three months ago.
Recommendations:
” A study of COVID-19 vaccine approval throughout 23 countries in 2022″ by Jeffrey V. Lazarus, Katarzyna Wyka, Trenton M. White, Camila A. Picchio, Lawrence O. Gostin, Heidi J. Larson, Kenneth Rabin, Scott C. Ratzan, Adeeba Kamarulzaman and Ayman El-Mohandes, 9 January 2023, Nature Medicine.DOI: 10.1038/ s41591-022-02185-4.
” Revisiting COVID-19 vaccine hesitancy worldwide using information from 23 countries in 2021″ by Jeffrey V. Lazarus, Katarzyna Wyka, Trenton M. White, Camila A. Picchio, Kenneth Rabin, Scott C. Ratzan, Jeanna Parsons Leigh, Jia Hu and Ayman El-Mohandes, 1 July 2022, Nature Communications.DOI: 10.1038/ s41467-022-31441-x.
According to a study of 23 countries, representing over 60% of the worlds population, international approval of COVID-19 vaccines rose from 75.2% in 2021 to 79.1% in 2022. However, there were some problems as vaccine acceptance declined in 8 nations. Furthermore, the study exposed that some vaccinated individuals, particularly younger men and ladies, were hesitant about getting a booster dose.
By providing international information on COVID-19 vaccine acceptance over three years, this brand-new research study can assist policymakers address vaccine hesitancy better.
Approval of COVID-19 vaccines increased globally, from 75.2% in 2021 to 79.1% in 2022, according to a study in 23 countries that represent more than 60% of the worlds population. Nevertheless, vaccine acceptance reduced in 8 countries and nearly one in 8 vaccinated participants, especially younger ladies and men, were reluctant about getting a booster dosage. Led by the Barcelona Institute for Global Health (ISGlobal) and the CUNY Graduate School of Public Health and Health Policy (CUNY SPH) and released on January 9 in the journal Nature Medicine, the study underlines a large irregularity among nations and the requirement for tailored interaction techniques in resolving vaccine hesitancy
” The pandemic is not over, and authorities should urgently deal with vaccine hesitancy and resistance as part of their COVID-19 avoidance and mitigation technique,” says Jeffrey V Lazarus, Head of the Health Systems Research Group at ISGlobal, an organization supported by “la Caixa” Foundation. To do so effectively, however, policy-makers need solid data on vaccine hesitancy trends (whether it is increasing or decreasing and in which populations) and chauffeurs (factors that influence vaccine approval, such as earnings or education).
According to a survey of 23 countries, representing over 60% of the worlds population, international approval of COVID-19 vaccines rose from 75.2% in 2021 to 79.1% in 2022. Acceptance of COVID-19 vaccines increased globally, from 75.2% in 2021 to 79.1% in 2022, according to a study in 23 countries that represent more than 60% of the worlds population. Vaccine acceptance decreased in eight countries and almost one in 8 vaccinated participants, especially more youthful ladies and men, were reluctant about receiving a booster dosage. The determination of moms and dads to vaccinate their children also rose a little, from 67.6% in 2021 to 69.5% in 2022. 8 nations observed increased hesitancy (from 1.0% in the UK to 21.1% in South Africa).
